Literature DB >> 6805003

Training dose as a factor in LSD-saline discrimination.

F J White, J B Appel.   

Abstract

To assess the effects of training dose on the discriminative stimulus properties of LSD, groups of rats (eight/group) were trained to discriminate each of three doses of LSD (0.02, 0.08 or 0.32 mg/kg) from saline. This was accomplished by using a method of progressively altering dose ("fading"). Dose-response tests revealed that the three LSD cues were specific to the dose used during training and that, as the training dose declined, the slope of the LSD dose-response curve became less steep. Substitution tests with direct serotonin (5-HT) agonists (quipazine, MK-212, 5-methoxy-N,N-dimethyltryptamine) and antagonism tests with central 5-HT antagonists (methiothepin and cyproheptadine) indicated that 5-HT is involved in mediating the in vivo effects of LSD and that training dose co-determines (along with the dose of the test compound) the extent of substitution or antagonism. In addition, substitution tests with the peripherally-active 5-HT agonist 5-methoxytryptamine and 5-HT antagonist xylamidine suggested that the peripheral serotonergic actions of LSD may be involved (in part) in the low dose (0.02 mg/kg) LSD cue. In contrast to 5-HT, dopamine (DA) did not appear to be involved in the discriminative stimulus properties of LSD, because no significant dose or group effects were seen during tests with the DA agonists apomorphine and d-amphetamine or the DA antagonist haloperidol.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805003     DOI: 10.1007/BF00430748

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  LSD as an agonist at mesolimbic dopamine receptors.

Authors:  P H Kelly; L L Iversen
Journal:  Psychopharmacologia       Date:  1975-12-31

2.  Stereotyped and non-stereotyped behaviour in rats induced by various stimulant drugs.

Authors:  R Fog
Journal:  Psychopharmacologia       Date:  1969

3.  LSD as an agonist of dopamine receptors in the striatum.

Authors:  L Pieri; M Pieri; W Haefely
Journal:  Nature       Date:  1974-12-13       Impact factor: 49.962

4.  A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD).

Authors:  I D Hirschhorn; J A Rosecrans
Journal:  Pharmacol Biochem Behav       Date:  1974-05       Impact factor: 3.533

5.  Identification and quantitation of a new indolealkylamine in rat hypothalamus.

Authors:  A R Green; S H Koslow; E Costa
Journal:  Brain Res       Date:  1973-03-15       Impact factor: 3.252

Review 6.  Speculations on the mechanism of action of hallucinogenic indolealkylamines.

Authors:  R A Glennon; J A Rosecrans
Journal:  Neurosci Biobehav Rev       Date:  1981       Impact factor: 8.989

7.  Discriminative stimulus effects of cyclazocine in the rat.

Authors:  J J Teal; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1980-03       Impact factor: 4.030

8.  Factors regulating drug cue sensitivity: limits of discriminability and the role of a progressively decreasing training dose in fentanyl-saline discrimination.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  J Pharmacol Exp Ther       Date:  1980-03       Impact factor: 4.030

9.  Morphine as a discriminative cue in gerbils: drug generalization and antagonism.

Authors:  T U Järbe; C Rollenhagen
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

10.  Drug discrimination training with progressively lowered doses.

Authors:  D A Overton
Journal:  Science       Date:  1979-08-17       Impact factor: 47.728

View more
  22 in total

1.  Discriminative stimulus properties of the serotonin agonist MK 212.

Authors:  K A Cunningham; P M Callahan; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Early preclinical studies of discriminable sedative and hallucinogenic drug effects.

Authors:  Herbert Barry; James B Appel
Journal:  Psychopharmacology (Berl)       Date:  2008-08-20       Impact factor: 4.530

3.  Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine.

Authors:  Daniel Kueh; Lisa E Baker
Journal:  Psychopharmacology (Berl)       Date:  2006-09-23       Impact factor: 4.530

4.  Effects of training dose on discrimination and cross-generalization of chlordiazepoxide, pentobarbital and ethanol in the rat.

Authors:  J De Vry; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  The effect of drugs on the acquisition of stimulus control in a conditioned suppression procedure.

Authors:  E B Nielsen; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 6.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity.

Authors:  Anya K Bershad; Katrin H Preller; Royce Lee; Sarah Keedy; Jamie Wren-Jarvis; Michael P Bremmer; Harriet de Wit
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-12-20

8.  Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle.

Authors:  Robert E Vann; Laura E Wise; Stephen A Varvel; Scott D Philibin; D Matthew Walentiny; Joseph H Porter
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

9.  Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.

Authors:  P M Callahan; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.

Authors:  D Fiorella; R A Rabin; J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.